---
title: "Indian Infotech and Software Ltd (509051) — Share Price, Financials & Analysis"
symbol: "509051"
company: "Indian Infotech and Software Ltd"
canonical: "https://tapetide.com/stocks/509051"
isin: "INE300B01022"
nse_symbol: "INDIANINFOTECHSOFTWARELTD"
bse_code: "509051"
sector: "Financial Services"
industry: "Investment Company"
market_cap_cr: 87.81
generated_at: "2026-09-13T19:59:51.015Z"
---

# Indian Infotech and Software Ltd (509051)

Canonical page: https://tapetide.com/stocks/509051

## Company

- **NSE Symbol:** INDIANINFOTECHSOFTWARELTD
- **BSE Code:** 509051
- **ISIN:** INE300B01022
- **Sector:** Financial Services
- **Industry:** Investment Company
- **Macro Sector:** Financial Services
- **Stock Type:** EQUITY
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** indianinfotech.org

## About

Incorporated in 1982, Indian Infotech 
and Software Ltd provides loans and 
does trading of shares[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:38:18.882942Z.

- **Market Cap:** ₹87.81 Cr
- **Classification:** Microcap
- **P/E (reported):** 0
- **EPS (TTM):** ₹0.01
- **EPS (reported):** ₹0.01
- **Book Value:** ₹1.85
- **Price to Book:** 0.29
- **Dividend Yield:** 0%
- **ROE:** 0.23%
- **ROCE:** 0.47%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹82.5 Cr
- **Net Income:** ₹0.6 Cr
- **EBITDA:** ₹82.9 Cr
- **52-Week High:** ₹1.12
- **52-Week Low:** ₹0.47
- **RSI (14):** 36.5

## Tapetide Score

- **Score:** 49 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 43.6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 55.64 | 9% |
| growth | 85 | 9% |
| momentum | 32.21 | 12% |
| ownership | 50 | 24% |
| quality | 42.45 | 22% |
| valuation | 42.77 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Stock is trading at 0.29 times its book value
- Company's working capital requirements have reduced from 2,414 days to 63.5 days

### Weaknesses

- The company has delivered a poor sales growth of 9.26% over past five years.
- Promoter holding is low: 11.5%
- Company has a low return on equity of -0.47% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 15.04% | -103.01% | -180.93% |
| ebitda margin growth | -71.43% | — | — | — |
| net income growth | -83.33% | 106% | 31% | 16% |
| revenue growth | -36.91% | 80% | 11% | 9% |
| roce | -76.81% | — | — | — |
| roe | -83.08% | — | — | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 6.05 | 5.41 | 4.75 | 17.59 | 11.65 | 6.08 | 4.11 | 10.72 | 11.63 | 5.83 | 35.92 | 5.28 |
| Expenses | 0.88 | 0.65 | 16.82 | 13.36 | 4.91 | 18.39 | 9.44 | 7.15 | 7.82 | 6.67 | 40.6 | 2.92 |
| Operating Profit | 5.17 | 4.76 | -12.07 | 4.23 | 6.74 | -12.31 | -5.33 | 3.57 | 3.81 | -0.84 | -4.68 | 2.36 |
| OPM % | 85.45 | 87.99 | -254.11 | 24.05 | 57.85 | -202.47 | -129.68 | 33.3 | 32.76 | -14.41 | -13.03 | 44.7 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 5.17 | 4.76 | -12.07 | 4.23 | 6.74 | -12.31 | -5.33 | 3.57 | 3.81 | -0.84 | -4.68 | 2.36 |
| Tax % | 25.15 | 25.21 | -24.94 | 31.21 | 31.16 | -25.18 | 4.69 | 25.77 | 25.72 | 0 | -30.34 | 25.85 |
| Net Profit | 3.87 | 3.56 | -9.06 | 2.91 | 4.63 | -9.21 | -5.57 | 2.65 | 2.83 | -0.84 | -3.26 | 1.75 |
| EPS in Rs | 0.02 | 0.02 | -0.05 | 0.02 | 0.03 | -0.05 | -0.03 | 0.02 | 0.02 | 0 | -0.02 | 0.01 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 10.55 | 11.13 | 12.91 | 41.18 | 55.39 | 47.06 | 21.12 | 39.43 | 64.11 | 58.66 |
| Expenses | 0.28 | 0.53 | 4.17 | 42.22 | 54.96 | 46.28 | 18.8 | 46.1 | 62.25 | 58.01 |
| Operating Profit | 10.27 | 10.6 | 8.74 | -1.04 | 0.43 | 0.78 | 2.32 | -6.67 | 1.86 | 0.65 |
| OPM % | 97.35 | 95.24 | 67.7 | -2.53 | 0.78 | 1.66 | 10.98 | -16.92 | 2.9 | 1.11 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0.01 | 3.47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 10.32 | 10.32 | 10.32 | 10.32 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.05 | 0.27 | -5.05 | -11.36 | 0.43 | 0.78 | 2.32 | -6.67 | 1.86 | 0.65 |
| Tax % | -1920 | -203.7 | -1.19 | 0 | 25.58 | 21.79 | 26.29 | 3.75 | 25.81 | — |
| Net Profit | 0.91 | 0.82 | -4.99 | -11.36 | 0.32 | 0.61 | 1.72 | -6.92 | 1.38 | 0.48 |
| EPS in Rs | 0.01 | 0 | -0.03 | -0.07 | 0 | 0 | 0.01 | -0.04 | 0.01 | 0.01 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 100.56 | 100.56 | 100.56 | 100.56 | 100.56 | 100.56 | 100.56 | 126.7 | 126.7 | 167.44 |
| Reserves | 144.97 | 146.1 | 146.9 | 141.05 | 128.36 | 128.68 | 129.25 | 145.12 | 138.19 | 143.49 |
| Borrowings | 0 | 0.54 | 0 | 0 | 0.3 | 0.3 | 0.3 | 0 | 0 | 0 |
| Other Liabilities | 10.36 | 0.56 | 0.78 | 0.51 | 0.6 | 0.7 | 0.84 | 1.34 | 1.55 | 2.27 |
| Total Liabilities | 255.89 | 247.76 | 248.24 | 242.12 | 229.82 | 230.24 | 230.95 | 273.16 | 266.44 | 313.2 |
| Fixed Assets | 41.29 | 30.96 | 20.64 | 10.32 | 0 | 0 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.41 | 0.41 | 41.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 214.19 | 216.39 | 185.9 | 231.8 | 229.82 | 230.24 | 230.95 | 273.16 | 266.44 | 313.2 |
| Total Assets | 255.89 | 247.76 | 248.24 | 242.12 | 229.82 | 230.24 | 230.95 | 273.16 | 266.44 | 313.2 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 25.14 | -11.48 | 30.77 | -25.52 | 11.58 | 11.37 | 7.37 | -59.19 | -14.27 | 0 |
| Cash from Investing Activity | 0 | 0 | -41.29 | 41.7 | -11.01 | -10.93 | -9.77 | 19.37 | 13.88 | 0 |
| Cash from Financing Activity | -26.38 | 11.09 | 10.47 | -16.16 | 0.3 | 0 | 0 | 40.01 | 0.2 | 0 |
| Net Cash Flow | -1.24 | -0.39 | -0.05 | 0.02 | 0.86 | 0.44 | -2.4 | 0.19 | -0.2 | 0 |
| Free Cash Flow | 25.14 | -11.48 | 30.77 | -25.52 | 11.58 | 11.37 | 7.37 | -59.19 | -14.27 | 0 |
| CFO/OP | 237 | -112 | 290 | -292 | -1113 | 2644 | 945 | -2551 | 214 | 0 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.41 | 0 | 0 |
| Inventory Days | — | — | — | — | 88.89 | 68.89 | 1.96 | — | 275.62 | 45.42 |
| Days Payable | — | — | — | — | 0.44 | 0.07 | 0.16 | — | 0 | 0 |
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 88.46 | 68.82 | 1.79 | 11.41 | 275.62 | 45.42 |
| Working Capital Days | 197.47 | 148.42 | -25.91 | 1236.36 | 95.55 | 80 | 20.55 | 4714.24 | 2464.75 | 63.54 |
| ROCE % | 0.1 | -0.02 | 0.11 | -0.65 | -4.83 | 0.19 | 0.34 | 0.92 | -2.49 | 0.65 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 8.07% | 7.04% | 3.2% | 3.2% | 3.2% | 3.2% | 3.2% | 3.2% | 11.53% | 11.53% | 11.53% | 11.53% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 81.96% | 83.19% | 88.39% | 89.12% | 90.21% | 90.17% | 87% | 87% | 69.3% | 73.32% | 74.3% | 74.3% |
| Others | 9.97% | 9.76% | 8.4% | 7.68% | 6.58% | 6.63% | 9.8% | 9.8% | 19.17% | 15.15% | 14.17% | 14.17% |
| No. of Shareholders | 321950 | 341902 | 415175 | 418006 | 432904 | 455201 | 454993 | 454993 | 442719 | 439039 | 431778 | 431778 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 4 / 3 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 0.55 | Sell |
| EMA (10) | 0.55 | Sell |
| SMA (20) | 0.56 | Sell |
| EMA (20) | 0.56 | Sell |
| SMA (50) | 0.58 | Sell |
| EMA (50) | 0.58 | Sell |
| SMA (100) | 0.6 | Sell |
| EMA (100) | 0.6 | Sell |
| SMA (200) | 0.64 | Sell |
| EMA (200) | 0.67 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 36.5 | Neutral |
| MACD (12,26,9) | -0.01 | Sell |
| Stochastic (14,3,3) | 10.32 | Buy |
| ADX (14) | 26.71 | Buy |
| Williams %R (14) | -85.71 | Buy |
| ATR (14) | 0.02 | High Volatility |
| ROC (12) | -8.62 | Sell |
| Stoch RSI (14) | 1.54 | Buy |
| UO (7,14,28) | 36.36 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Meeting moved to 14-Feb-2026 to approve results for quarter ended 31-Dec-2025; trading window closed till 16-Feb-2026. | [Board Meeting Intimation for Notice Regarding Postponement And Rescheduling Of The Board Meeting. 9 Feb - Meeting moved to 14-Feb-2026 to approve results for quarter ended 31-Dec-2025; trading window closed till 16-Feb-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8541bd87-d1ca-4c1e-9ba4-8fa956f4d565.pdf) |
| 9 Apr - Regulation 74(5) certificate submitted for quarter ended 31 March 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Apr - Regulation 74(5) certificate submitted for quarter ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4e85c797-73e1-432b-9691-a6807316407a.pdf) |
| 7 Feb - Of Investor Presentation under Regulation 30 of SEBI (LODR) Regulations, 2015 | [Announcement under Regulation 30 (LODR)-Investor Presentation 7 Feb - Of Investor Presentation under Regulation 30 of SEBI (LODR) Regulations, 2015](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ee6715a1-877d-4c1f-856d-d65eea91939f.pdf) |
| 29 Apr - Company confirms it is not a Large Corporate; outstanding borrowing was zero as of 31 March 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 29 Apr - Company confirms it is not a Large Corporate; outstanding borrowing was zero as of 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/deb50319-b326-4cd0-8c18-a97041f0dbe2.pdf) |
| 29 Apr - Company confirms it is not a Large Corporate; outstanding borrowing was zero as of 31 March 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 29 Apr - Company confirms it is not a Large Corporate; outstanding borrowing was zero as of 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/deb50319-b326-4cd0-8c18-a97041f0dbe2.pdf) |
| 26 Feb - 26 Feb 2026: Aptus Pharma expanding into life-saving injectables and ICU care for hospital use. | [Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015: Business Expansion 26 Feb - 26 Feb 2026: Aptus Pharma expanding into life-saving injectables and ICU care for hospital use.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0f0dd505-8c88-410a-911f-368633968f21.pdf) |
| 25 Mar - Trading window closed from 01-Apr-2026 until 48 hours after board meeting for audited results (year ended 31-Mar-2026). | [Closure of Trading Window 25 Mar - Trading window closed from 01-Apr-2026 until 48 hours after board meeting for audited results (year ended 31-Mar-2026).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/15d47e6f-1ae3-4581-acee-549ffebadbc1.pdf) |
| 24 Feb - Aptus Pharma awarded 'Fastest Growing Ethical Pharma Company' by News18; presented by Gujarat Deputy CM on 24-Feb-2026. | [Intimation Of Award Received: Recognition As Fastest Growing Ethical Pharma Company 24 Feb - Aptus Pharma awarded 'Fastest Growing Ethical Pharma Company' by News18; presented by Gujarat Deputy CM on 24-Feb-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/408648d7-2269-4287-98f3-d7c167e0291d.pdf) |
| 21 Nov 2025 - Aptus Pharma entering urology, launching Silodosin/Tamsulosin/alkalizers; 150+ distributors; announced Nov 21, 2025. | [Regulation 30 Disclosure - Entry Into The Urology Therapy Segment 21 Nov 2025 - Aptus Pharma entering urology, launching Silodosin/Tamsulosin/alkalizers; 150+ distributors; announced Nov 21, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c4c72e02-3fea-4207-8a9b-0f72fe69fd3b.pdf) |
| 21 Feb - Newspaper publication of Unaudited Financial Results of the Company for the quarter and nine Months ended December 31 2025. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 21 Feb - Newspaper publication of Unaudited Financial Results of the Company for the quarter and nine Months ended December 31 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a9e499e9-901a-4d70-96fb-079fd171a911.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-09 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c3f7777-1194-4741-833d-1d0e4a8c5e99.pdf) |
| 2026-09-08 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72edf3fb-e671-45cd-8b5d-f571694e004c.pdf) |
| 2026-09-08 | [Notice Of 44Th Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e86a4708-f202-4dbb-8ee7-100083c1b92a.pdf) |
| 2026-09-08 | [Fixed Book Closure For AGM Purpose](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea950d64-0fac-4c71-9130-f5816dc98eac.pdf) |
| 2026-09-05 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a24452d-cb78-45c1-b98c-81db0cfb8978.pdf) |
| 2026-09-05 | [Appointment Of Internal Auditor](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31056208-112d-41aa-9bff-ffafccbfd5f9.pdf) |
| 2026-09-05 | [Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc64231c-513b-449c-ad40-7d6c2b0ea8bf.pdf) |
| 2026-09-05 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1bb70788-8029-4391-b5df-e560658846b1.pdf) |
| 2026-09-03 | [Board Meeting Intimation for Intimation Regarding Adjournment Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06cfa293-d17b-42e8-a47b-d4c1fb6fb2d7.pdf) |
| 2026-08-27 | [Board Meeting Intimation for Meeting Of Board Of Directors Of Indian Infotech And Software Limited Is Schedule To Be Held On Thursday 03Rd September 2026 .](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16a3ac02-3cc5-49ff-a868-14dc5353e2f8.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-14 | [Financial Result](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8ed3aa6-0067-4c80-9bd1-c38962404cbf.pdf) |
| 2026-05-30 | [Results For The Financial Year 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4f0dfdf-4c3b-4f02-a815-6e2eca518ce6.pdf) |
| 2026-02-14 | [Unaudited Financial Result For The Quarter Ended December 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ff568ba-ec9b-4966-9683-ab2bd30da876.pdf) |
| 2025-11-13 | [Results-September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59894d3e-89b4-4343-835f-6e8baf666b2a.pdf) |
| 2025-11-13 | [Result September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f50342d9-2e50-4e84-bf90-ad0e59551348.pdf) |
| 2025-08-06 | [June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7eb2ea6f-81c2-460b-9d22-81a15fe5ed6e.pdf) |
| 2025-05-28 | [March 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ab8da9f-c255-44f1-9734-caa0ee1eed64.pdf) |
| 2025-02-19 | [Revised And Corrigendum To Unaudited Financial Results (Standalone ) For The Third Quarter And Nine Months Ended December 31 2024 Submitted To The Exchange On 13Th February 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=920e218d-8500-455e-b6af-f79660d2066c.pdf) |
| 2025-02-13 | [December Financial Result -2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02063da3-6e0d-4701-8a07-9f0e0eb2b338.pdf) |
| 2024-11-14 | [Results - September Quarter 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49d9a280-522c-430c-9cd4-523176b3c422.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/39248a7c-7679-43a1-bd34-5e4de6af9084.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f0ad9447-c1ab-4d1f-b89d-eecc5479064d.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/29d35b8d-28e8-4c0e-a31a-3f550c33ff0e.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/509051/76389509051_22_09_22.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/509051/72724509051_18_05_22.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/509051/67972509051.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/509051/5090510319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/509051/5090510318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/509051/5090510317.pdf) |
| from bse | [Annual Report 2016 from bse](https://www.bseindia.com/bseplus/AnnualReport/509051/5090510316.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:59:51.015Z.